Oral Drug Delivery Resources
-
Making A Case For A Fixed Dose Combination Drug Strategy
As patient-centricity spurs innovation in drug delivery systems, examine the potential of FDCs to provide convenient dosing and how increased patient compliance is alleviating the cost of health care.
-
Making The Right Choice For Multiparticulate Modified Release Dosage Forms
4/2/2021
Wurster processing is a versatile pharmaceutical development and manufacturing technique for multiparticulates in modified release dosage forms. Understand if it's the right method for your modified-release project.
-
Streamline Early-Stage Development To Reach The Clinic Faster
7/17/2023
Early-stage development is an iterative process, continuously generating new data and insights to optimize the product based on emerging knowledge.
-
Enabling Long Lasting Clinical Outcomes In Coronary Stenting
9/12/2022
Polyester amides (PEAs) bring several desired and differentiating properties to drug-eluting stent (DES) applications for treating coronary artery disease (CAD).
-
Solving For The Future Of Drug Delivery
7/16/2025
Next-gen therapeutics require equally advanced delivery systems—localized, personalized, and precise—to ensure efficacy, safety, and scalability. Delivery is now a central driver of innovation.
-
Solutions For Accelerated Pharmaceutical Development
Explore an integrated service package designed to simplify and accelerate the development pathway, even for APIs with challenging properties such as low aqueous solubility and poor bioavailability.
-
Achieve Release Profiles And Select Excipients For Formulation Development
5/2/2020
The formulation and manufacture of modified-release OSD forms are highly specialized. Review considerations for planning and executing a successful modified release oral solid dosage formulation.
-
Reducing Environmental Impact At All Stages Of The Medicine Journey
Explore how utilizing technologies like AI and digital twinning can inform decision-making at the R&D stage and how to optimize the delivery of the final drug product to patients with greener logistics.
-
Steps To Overcome Challenges Associated With Biologic Formulation Development
8/24/2022
Explore guidance on the challenges posed by biologics, including overcoming degradation, establishing a stress test process, and the value of lipid nanoparticles (LNPs) and polymeric nanoparticles (NPs).
-
Are Drugs Becoming More Lipophilic Over Time?
Get a deeper look into how drug lipophilicity has evolved over time, its impact on drug development, and the need for new technology to enable new more complex drugs.